Transatlantique Private Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Transatlantique Private Wealth's AMGN Position: Q4 2025 in Review
Transatlantique Private Wealth sold out of Amgen (AMGN) in Q4 2025, closing a stake of 2,628 shares — an estimated $742K sold.
Transatlantique Private Wealth first reported a position in AMGN in Q2 2022 and held it in 14 quarters. The position peaked at $1.12M in Q3 2024. 3,086 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Transatlantique Private Wealth reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
- Transatlantique Private Wealth sold 2,628 Amgen shares in Q4 2025, an estimated $742K.
- Transatlantique Private Wealth first reported a position in Amgen in Q2 2022 and held it in 14 quarters.
- Transatlantique Private Wealth's Amgen position peaked at $1.12M in Q3 2024.
- 3,086 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Transatlantique Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.